104 related articles for article (PubMed ID: 3204279)
21. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
[TBL] [Abstract][Full Text] [Related]
22. Flu like syndrome with rifampicin pulse therapy.
Parking AA; Shah BH
Indian J Lepr; 1989 Apr; 61(2):209-10. PubMed ID: 2746030
[TBL] [Abstract][Full Text] [Related]
23. Leprosy in a preschool child--a case report.
Arora SK
J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
[TBL] [Abstract][Full Text] [Related]
24. Reversible acute renal failure due to monthly administration of rifampicin in a leprosy patient.
Kar HK; Roy RG
Indian J Lepr; 1984; 56(4):835-9. PubMed ID: 6549453
[TBL] [Abstract][Full Text] [Related]
25. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Mendis S; Somasiri KG; Chularatna W
Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
[TBL] [Abstract][Full Text] [Related]
26. Acute renal failure--a complication of new multidrug regimen for treatment of leprosy.
Dedhia NM; Almeida AF; Khanna UB; Mittal BV; Acharya VM
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):380-2. PubMed ID: 3746041
[TBL] [Abstract][Full Text] [Related]
27. Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
Jamet P; Blanc L; Fayne OC; Traore I; Bobin P
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):209-14. PubMed ID: 8046259
[TBL] [Abstract][Full Text] [Related]
28. High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.
Nijland HM; L'homme RF; Rongen GA; van Uden P; van Crevel R; Boeree MJ; Aarnoutse RE; Koopmans PP; Burger DM
AIDS; 2008 May; 22(8):931-5. PubMed ID: 18453852
[TBL] [Abstract][Full Text] [Related]
29. Adverse reactions to rifampicin.
Girling DJ; Hitze KL
Bull World Health Organ; 1979; 57(1):45-9. PubMed ID: 311712
[TBL] [Abstract][Full Text] [Related]
30. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
Rea TH
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
[TBL] [Abstract][Full Text] [Related]
31. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
Paul S; Rose ET
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
[No Abstract] [Full Text] [Related]
32. Effect of probenecid on serum rifampicin levels.
Pankaj R; Lal S; Rao RS
Indian J Lepr; 1985; 57(2):329-33. PubMed ID: 4078358
[TBL] [Abstract][Full Text] [Related]
33. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
35. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Armour KS; Scolyer RA; Barnetson RS
Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy of leprosy.
Biswas SK;
J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
[TBL] [Abstract][Full Text] [Related]
37. An unusual reaction to rifampicin in a once monthly dose.
Sule RR
Lepr Rev; 1996 Sep; 67(3):227-8. PubMed ID: 8885617
[No Abstract] [Full Text] [Related]
38. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
Katoch K; Ramu G; Ramanathan U
Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
Reyes-Javier PD; Tantiongco PR
Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
[No Abstract] [Full Text] [Related]
40. [Systemic collateral effects of intermittent antituberculous treatments with rifampicin].
Decroix G; Pujet JC
Rev Tuberc Pneumol (Paris); 1971 Nov; 35(7):733-43. PubMed ID: 5151216
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
